Related Experiment Videos
Microcomputer-assisted data management for multiinstitutional pediatric clinical cancer trials.
The American Journal of Pediatric Hematology/Oncology
|January 1, 1987
Summary
Microcomputer data management improved oversight in pediatric acute lymphoblastic leukemia trials. This led to timely treatment modifications and halted ineffective therapies, enhancing clinical trial quality and patient outcomes.
Area of Science:
- Pediatric Oncology
- Clinical Trial Management
- Health Informatics
Background:
- Multi-institutional trials in pediatric oncology require robust data management.
- Effective oversight is crucial for ensuring data integrity and timely therapeutic adjustments.
- Acute lymphoblastic leukemia (ALL) in children with unfavorable prognosis necessitates precise treatment protocols.
Purpose of the Study:
- To present microcomputer-assisted data management techniques for overseeing pediatric ALL trials.
- To demonstrate the impact of data management on clinical trial quality and patient care.
- To highlight the role of performance monitoring in multi-institutional studies.
Main Methods:
- Utilized microcomputer-assisted data management for two multi-institutional trials in children with previously untreated ALL.
- Implemented performance monitoring to assess data completeness and protocol adherence.
- Analyzed institutional participation quality and identified reporting deficiencies.
Main Results:
- Oversight facilitated rapid identification of treatment delays, enabling successful modification in the first study.
- The second study demonstrated the inferiority of a specific therapy, leading to its prompt discontinuation.
- Performance monitoring provided insights into data completeness and protocol administration accuracy.
Conclusions:
- Microcomputer-assisted data management enhances the quality and efficiency of multi-institutional pediatric cancer trials.
- Real-time performance monitoring is vital for adaptive trial management and patient safety.
- Effective data oversight can lead to significant improvements in treatment strategies and outcomes for childhood ALL.